Improving quality of life and outcomes for cancer patients, through the first noninvasive white blood cell monitoring device. Spun out from @MIT @La_UPM
#EnnovaHealthDay | 💡 Es el momento de descubrir seis proyectos de éxito para conectar la innovación en salud:
Comenzamos con Álvaro Sánchez Ferro (@alvaroravla), nos habla de @LEUKO, empresa de la que es CMO y cofundador.
🚨 New Opportunity! 🚨
Leuko is hiring a Senior Manufacturing/Hardware Engineer in Boston! If you have experience in #manufacturing with #medicaldevices and are driven to make a difference in #cancercare, we'd like to hear from you!
🔗 Apply at https://t.co/1SKSEv6Ylv
Thrilled to announce a $4.5m SBIR award from @NCIsbir to advance our next stage of clinical development! Thanks to @NIH, our investors, and the Leuko team for their dedication. This investment accelerates our #noninvasive solution for #cancer patients.💫 https://t.co/Ui3GcWox4R
🚀 Groundbreaking News from @leuko , an @MITSTEX company! 🚀
@leuko is revolutionizing cancer care with a noninvasive white blood cell monitor, recently featured in MIT News. No more invasive blood tests! 🩺✨
Full story:https://t.co/BFVqBHEAbF
Hemos estado en el #WMC presentando el proyecto 5G Blood diagnostic de #hematología con nuestros colaboradores para transformar el cáncer en esperanza ¡Gracias a los participantes!
@telefonica, @leuko, Prof. Pilar Llamas y la dra. Sara Martín.
#4YFN#EsperanzaEnCáncer
Today @Leuko joined @GSK, @Telefonica and Hospital Fundación Jiménez Díaz in an onco-hematology innovation round table organized by GSK at the #MobileWorldCongress. We're excited to kick off this collaboration to make a difference in the lives of people with hematological cancer!
Impresionado por el uso de la tecnología de vanguardia por nuestras empresas innovadoras, desde medir tallas a contar glóbulos blancos, pasando por gestionar pagos, automatizar procesos de venta o entrenar modelos #IA#Aitaca#esave @MultiverseQC @devengoapi@leuko#SpainMWC24
Join on Zoom Tuesday, 9/12 from 6-7:30 PM ET for a MIT VMS Impact Working Group Virtual Event: Launching & Funding a Digital Health Company, The @leuko story, with @goodgrowthvc and @massventures
Learn more and register: https://t.co/1AqqKJyFyW
NEW JOB ALERT! 🚨
We're #hiring! Looking for a talented Director of Manufacturing to join our Boston office.
Do you have #manufacturing experience with #medicaldevices and would like to make a difference in #healthcare?
Apply here: https://t.co/7mJLUhaLZ8
Thrilled to announce that we raised a $5m Series A led by HTH VC!
We're excited for the next chapter and how this investment will further accelerate bringing our #noninvasive solution for white blood cell monitoring to the hands of #cancer patients. 🚀
https://t.co/XshyEqZZMV
New data alert!! 🚨🚨🚨
PointCheck(TM), our device for at-home noninvasive white cell monitoring, demonstrates high usability in #cancer patients. #impact#innovation
Big kudos to our collaborators @The_BMC@SaludMadrid@MIT_IMES and @NCIsbir.
https://t.co/xSaoZ8ceXD
How @leuko is reviewing white blood cells without extracting blood: read more about PointCheck https://t.co/1FkVJ9TCNo via @ABCeconomia#cancer#oncology
👏Congratulations to the winners of the EIT Health Catapult 2022!
🩹@SolasCure wins the biotech category for its product Aurase.
🔎@leuko wins the medtech prize for PointCheck.
💻@ebenbuild wins the digital health category for its precision therapy for ARDS.